Home / Inspections / 1284932

FDA Inspection 1284932 — New York Blood Center Inc

New York Blood Center Inc — FEI 2170665

The FDA completed an inspection of New York Blood Center Inc on September 16, 2025 in St. Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 16, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
St. Paul, MN (United States)

Facility

Other inspections at this facility

  • 1254640 (NAI Fri Nov 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097900 (NAI Thu Jun 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004777 (NAI Fri Mar 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 946194 (VAI Wed Sep 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 861409 (VAI Wed Nov 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources